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Abstract
Background: The acquisition of multidrug resistance by Plasmodium falciparum underscores the need to understand
the underlying molecular mechanisms so as to counter their impact on malaria control. For the many antimalarials
whose mode of action relates to inhibition of heme detoxification inside infected erythrocytes, the digestive vacuole
transporters PfCRT and PfMDR1 constitute primary resistance determinants.
Results: Using gene expression microarrays over the course of the parasite intra-erythrocytic developmental cycle, we
compared the transcriptomic profiles between P. falciparum strains displaying mutant or wild-type pfcrt or varying in
pfcrt or pfmdr1 expression levels. To account for differences in the time of sampling, we developed a computational
method termed Hypergeometric Analysis of Time Series, which combines Fast Fourier Transform with a modified Gene
Set Enrichment Analysis. Our analysis revealed coordinated changes in genes involved
in protein catabolism, translation initiation and DNA/RNA metabolism. We also observed differential expression of
genes with a role in transport or coding for components of the digestive vacuole. Interestingly, a global comparison of
all profiled transcriptomes uncovered a tight correlation between the transcript levels of pfcrt and pfmdr1, extending to
dozens of other genes, suggesting an intricate regulatory balance in order to maintain optimal physiological processes.
Conclusions: This study provides insight into the mechanisms by which P. falciparum adjusts to the acquisition of
mutations or gene amplification in key transporter loci that mediate drug resistance. Our results implicate several
biological pathways that may be differentially regulated to compensate for impaired transporter function and
alterations in parasite vacuole physiology.
Keywords: Plasmodium falciparum, Antimalarial drug resistance, Comparative transcriptomics, Transporters, Fast fourier
transform, Gene set enrichment analysis, Hypergeometric analysis of time series
Background
With an estimated 214 million clinical cases and 438,000
deaths in 2015 [1] malaria remains one of the deadliest
infectious diseases. Clinical manifestations are due to
successive rounds of Plasmodium parasite invasion, rep-
lication within host erythrocytes, egress and re-invasion.
Present efforts to reduce mortality and morbidity focus
on the use of curative and preventive drug treatments
as well as on vector control strategies [2]. Those
include first-line artemisinin-based combination therap-
ies (ACTs) that pair a highly potent artemisinin
derivative with a longer-acting partner drug [3]. ACTs
currently constitute the best regimens to treat 4-
aminoquinoline- and antifolate-resistant Plasmodium
falciparum parasites that have swept across the world.
While 20 years were necessary for chloroquine (CQ) re-
sistance to spread from its origins in Southeast Asia to
Africa [4], resistance to the antifolate combination of
sulfadoxine-pyrimethamine disseminated at a much
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faster pace [5]. The recent emergence of delayed
parasite clearance following artesunate or ACT admin-
istration in Western Cambodia and Thailand [6–8]
reemphasizes the need to develop therapeutic strategies
to treat drug-resistant P. falciparum malaria and define
the molecular basis of resistance.
Two key genetic determinants of P. falciparum resist-
ance to antimalarial compounds are pfcrt [9] and pfmdr1
[10, 11], which encode transporter proteins that localize
to the digestive vacuole membrane of intra-erythrocytic
parasites. While their native biological functions remain
unknown, the inability to genetically disrupt pfcrt or
pfmdr1 provides evidence for their essentiality [12, 13].
Laboratory and field-based studies have demonstrated
that PfCRT mutations constitute the primary determin-
ant of in vitro CQ resistance and are associated with a
substantially increased risk of CQ treatment failure in
patients [14–16]. Studies with transgenic parasites or
heterologous expression systems have attributed PfCRT-
mediated CQ resistance to drug efflux out of the low-pH
digestive vacuole, where CQ becomes diprotonated, con-
centrates up to 1,000-fold and acts by binding to heme
products and preventing heme detoxification [17–20].
PfCRT mutations can also mediate cross-resistance to
amodiaquine and increase susceptibility to lumefantrine,
mefloquine and artesunate [15, 21, 22]. pfmdr1 muta-
tions as well as copy number variations have also been
shown to impact P. falciparum susceptibility to several
antimalarials [13, 22–26] presumably via drug transport
across the digestive vacuole [27].
For PfCRT and PfMDR1, acquired resistance muta-
tions, or in the case of pfmdr1 gene amplifications, are
thought to generally impart a fitness cost [28–31], pre-
sumably via altering their endogenous transport proper-
ties to the detriment of normal parasite development
and replication. In endemic settings, this fitness cost
manifests as a reduced prevalence of mutant pfcrt or
pfmdr1 following the release of selective drug pressure
[32–36]. However, additional mutations elsewhere in an
organism can compensate for the cost of acquiring re-
sistance [37, 38] and restore fitness, as shown for P. fal-
ciparum resistance to antifolates [39–41]. Furthermore,
the long-term propagation of drug-resistant strains even
in the absence of selective pressure suggests adaptive
mechanisms that counteract the detrimental effects of
resistance-conferring genetic changes [42].
Intriguingly, the question of how parasites transcrip-
tionally adjust in the long-term to the acquisition of
mutations or gene amplifications in drug resistance
transporters has scarcely been addressed. An earlier
comparison of the transcriptional profiles of pfcrt mu-
tant strains generated by CQ selection from a drug-
sensitive parasite line suggested a limited number of
changes in the parasite transcriptome [43]. That study,
however, was restricted to a single time point of P. fal-
ciparum development within the host erythrocytes and
as such it could not correct for temporal differences in
the intra-erythrocytic developmental cycle (IDC) be-
tween parasite lines. Indeed, while transcriptome studies
have suggested an inability of the parasite to transcrip-
tionally respond to short-term drug pressure [44, 45],
conceivably parasites may be able to evolve over mul-
tiple generations to states of optimal growth that adjust
for physiological impacts of altered sequence or expres-
sion of drug/solute transporters. This is a testable hy-
pothesis for PfCRT and PfMDR1, whose expression
kinetics are closely tied to the formation of the para-
site digestive vacuole during the trophozoite stage.
Changes in the transcriptome profile of these mutant
lines can be assessed in comparison with the carefully
documented timeline of tightly regulated gene expres-
sion patterns that characterize the P. falciparum IDC
[46–48]. These expression patterns underpin the bio-
logical processes of intracellular parasite development,
replication and egress with accompanying morpho-
logical changes as parasites progress from rings to
trophozoites to schizonts.
Here, we investigated how parasites adjusted transcrip-
tionally to genetic modification of pfcrt or pfmdr1,
resulting in altered drug resistance phenotypes following
long-term culture. Using DNA microarrays, we con-
ducted a genome-wide transcriptional profiling of genet-
ically modified isogenic P. falciparum strains with either
distinct PfCRT haplotypes or pfmdr1 functional copy
numbers throughout their 48-hour IDC. These previ-
ously engineered lines either display a loss of CQ resist-
ance following the removal of the K76T mutation [20]
(used epidemiologically as the primary molecular marker
of CQ resistance) or show increased susceptibility to
multiple antimalarial drugs (including mefloquine, lume-
fantrine, quinine and artemisinin) following genetic dis-
ruption of one of the two pfmdr1 copies present in the
multidrug resistant FCB line [26]. To analyze the data
we developed a computational method that combines
Fast Fourier Transform (FFT) and Gene Set Enrichment
Analysis (GSEA) to correct for temporal differences be-
tween samples and compare microarray data between
time series. We also used a reference pool of 11 profiled
parasite lines to distinguish between stochastically vari-
ant genes and gene expression differences of biological
significance, including those of subtle amplitude. Our
results revealed a striking and previously unreported
correlation between the expression levels of pfcrt and
pfmdr1, and identified several pathways whose regula-
tion was altered in response to changes in either
gene, reinforcing the hypothesis of their functional
interplay and the existence of coordinated functional
networks.
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Results
A Fast Fourier Transform-based method to align microarray
time series data between profiled isogenic parasite
cell lines
To assess the genomic impact of P. falciparum acquiring
genetic changes in transporters that mediate antimalarial
drug resistance, we profiled the transcriptome of mul-
tiple isogenic lines characterized by altered pfcrt and
pfmdr1 gene expression levels and/or corresponding
protein haplotypes (Table 1). We also transcriptionally
profiled the parental strains and performed both
gene-specific and combined comparative analyses of
the data sets.
The first data set (focusing on pfmdr1) included
FCBpfmdr1_3′KD, which was engineered via single-site
crossover-based disruption of one of the two pfmdr1
copies within the duplicated 100-kb genomic region of
the multidrug-resistant parasite strain FCB [26, 49]. This
resulted in a 50 % decrease in pfmdr1 gene expression
and a reduction of approximately 40 % in its protein
level (Additional file 1: Figure S1A). In addition to
FCBpfmdr1_3′KD and its parental line FCB, our transcrip-
tome analysis included 106/1, a parasite strain that
genetically is nearly identical to FCB [50]. FCB and
FCBpfmdr1_3′KD display the same PfCRT haplotype (in-
cluding the K76T mutation that is required for CQ re-
sistance), whereas 106/1 has a key difference at position
76 that expresses a lysine (K) and confers CQ suscepti-
bility [9, 51].
The second data set (pfcrt) included 7G8pfcrt_T76K and
7G8pfcrt_CTL parasite lines that were generated by allelic
exchange via single crossover recombination targeting
codon 76 of the mutant pfcrt allele in the CQ-resistant
strain 7G8 [20]. The encoded threonine residue was
back mutated to the wild-type lysine in 7G8pfcrt_T76K,
resulting in a complete loss of CQ resistance, whereas it
remained identical to 7G8 in the recombinant control
7G8pfcrt_CTL. Additionally, the two recombinant lines are
characterized by a two-fold reduction in pfcrt mRNA
and protein expression, allowing us to assess the impact
of both the acquisition/loss of a point mutation and al-
teration in gene expression (Additional file 1: Figure
S1B). Of note, 7G8pfcrt_CTL is only moderately CQ-
resistant, with a mean CQ IC50 value (109 nM) that is
close to half that of the parental 7G8 line (251 nM) by
virtue of the reduced PfCRT expression [20].
To conduct our comparative analysis, tightly syn-
chronous parasites were cultured for the length of a
complete IDC (~48 h). RNA was extracted from samples
collected every 6 h for 48 h and assayed on a 70-mer
DNA microarray, representing more than 5,350 P. falcip-
arum genes [52]. Alignment of each profiled time series
to the transcriptome of the reference strain 3D7 showed
small but significant differences in the IDC duration. In-
deed, the transgenic strains displayed a shorter life cycle
than their respective parents (Fig. 1a).
Given the resulting slight time shifts between the time
series, we developed a computational method to align
the microarray expression data and to ensure that our
comparative analysis would not be skewed by temporal
differences in the developmental stage of the different
parasite lines at the time of harvesting. We used FFT to
impute gene expression levels at 376 unassayed time
points to obtain a 7.5-minute resolution of each time
course (384 time points in total; see Methods, Additional
file 2: Table S1). To validate this approach, we first per-
formed a simulation using published transcriptome data
sets that constituted of hourly time course data for the
Table 1 Summary of the P. falciparum lines used in the study. Drug resistance phenotype and pfcrt/pfmdr1 phenotypes are
indicated
PfCRT haplotypee PfMDR1 haplotypee CN
Parasite Line Parent Rec. Drug Phenotype Genetic characteristic 72 74 75 76 220 271 326 356 371 86 184 1034 1042 1246
FCB – No Multi-drug
resistanta
2 pfmdr1 copies C I E T S E S I I N Y S N D 2
FCBpfmdr1_3′KD FCB Yes CQ-resistantb 1 pfmdr1 copy C I E T S E S I I N Y S N D 1
106/1 – No CQ-sensitive 2 pfmdr1 copies,
pfcrt K76
C I E K S E S I I N Y S N D 2f
7G8 – No CQ-resistant pfcrt K76T S M N T S Q D L R N F C D Y 1
7G8pfcrt_CTL 7G8 Yes Less CQ-resistantc pfcrt shorter 5′UTR,
T76
S M N T S Q D L R N F C D Y 1
7G8pfcrt_T76K 7G8 Yes CQ-sensitived pfcrt shorter 5′UTR,
K76
S M N K S Q D L R N F C D Y 1
CQ: chloroquine,CN: pfmdr1 copy number, CTL: control, KD: knockdown, Rec: Recombinant, UTR: Untranslated region
aResistant to chloroquine through pfcrt mutations and partially resistant to lumefantrine, mefloquine and quinine through pfmdr1 gene amplification
bGenetic ablation of 2nd pfmdr1 copy number led to increased susceptibility to lumefantrine, mefloquine and quinine
cReduced pfcrt expression through replacement of full-length 5′UTR with shorter version resulted in reduced level of CQ resistance
dReversion of PfCRT K76T to wild-type K76 led to loss of CQ resistance
eAmino acids that differ from wild-type haplotypes (reference sequence 3D7, not shown) are shown in bold
fTranscriptome and qRT-PCR studies indicated that 106/1 expresses the equivalent of a single pfmdr1 copy, despite having two physical copies
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strains HB3, Dd2 and 3D7 [48]. For each strain we selected
8 time points spread 6 h apart, from which we generated a
curve of 376 imputed points. Using Pearson correlation
values for gene expression, we then compared each actual
hourly time point to the imputed curve to identify the clos-
est matching time point. We observed that actual time
points from the original time courses matched imputed
time points that were fairly evenly spread along the
imputation-derived curve, with correlations of average 83–
91 % across the range of time points for each strain. This
suggests that the imputation method can work on datasets
that comprise only eight time points, such as ours.
Using our imputed data sets, we then applied a dy-





Fig. 1 Alignment of all time series to the 3D7 reference transcriptome reveal differences in growth rates between the profiled parasite lines. a
Plot of all time courses before temporal alignment of the transcriptome data. For each transcriptome data set, the original 8 time points of each
48-hour time course (corresponding to a single intra-erythrocytic developmental cycle (IDC)) were aligned to the transcriptome of 3D7 that earlier
had been elucidated at a one-hour resolution [46]. b Phaseograms of all parasite lines in the FCB set after dynamic time warping. Genes (on the
Y-axis) were ordered according to their phase of expression computed using Fast Fourier Transform (FFT), which interpolated expression levels at
unassayed time points. The resulting output generated a smooth sine curve with a single peak of maximum expression (shown in red, spanning
a heatpmap gradient to the minimum transcript levels shown in blue) for each gene across the entire 48-hour IDC. c Phaseograms of the three
parasite lines in the 7G8 set after dynamic time warping. d Principal Component Analysis (PCA) confirming the proper alignment of all
transcriptomes. The ~3,000 to ~3,500 genes represented in each transcriptome were used to generate a matrix of values that was
reduced to a tri-dimensional projection using PCA. The first two principal components accurately recover the progression of the lines
through the 48-hour lifecycle while the third principal component focuses on differences between the lines as symbolized by the size
of the circles. Circle colors refer to the parasite lines depicted in (a)
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(PCC) method to determine for each profiled parasite
line the optimal post-invasion time point (corresponding
to the first sampling time point) along the IDC (see
Methods). All time courses were then realigned to the
3D7 transcriptome and to each other when performing
pairwise comparisons (Additional file 3: Figure S2).
Phaseograms representing the transcriptome of each
strain were assembled by hierarchically clustering the
mean-centered log2 expression ratios of the genes that
passed the different filters (~3,500 genes), according to
their phase of expression calculated as described above.
Transcriptomes of all strains reproduced the cascade of
expression typical of P. falciparum, in which genes are
expressed in a highly periodic mode [46] (Fig. 1b, c).
Furthermore, all profiled strains demonstrated excellent
synchronicity, with tight clustering of the expression
data as observed using Principal Component Analysis
(PCA), thereby validating the alignment of the time
series (Fig. 1d).
Chromosomal mapping of gene expression changes
reveals amplicon loss on chromosome 5 in FCBpfmdr1_3′KD
and down-regulation of a chromosome 2 gene cluster in
7G8pfcrt_T76K
To identify genes that were differentially expressed be-
tween parasite time series within each data set, steady
state transcript levels were analyzed across the IDC for
each profiled strain and compared to each other. We
computed gene expression fold differences for each pair-
wise comparison as the difference between the areas
under the curves, which were extracted from absolute
temporal gene expression plots derived from the full 384
time point data.
We then generated chromosome maps in which fold
changes in expression were plotted as a function of the
chromosomal position of each gene. These maps re-
vealed clusters of differential expression in telomeric
regions of several chromosomes, possibly indicating hy-
pervariable transcription of genes within these regions,
as previously reported [53] (Additional file 4: Figure S3).
Surprisingly, an entire set of genes all located on
chromosome 5 and overlapping with the 100-kb
amplicon containing pfmdr1 (PF3D7_0523000) ap-
peared to be differentially expressed between FCB
and both FCBpfmdr1_3′KD and 106/1 (Fig. 2a, b). All
genes within this region except PF3D7_0521300,
PF3D7_0521800, PF3D7_0522900, and PF3D7_0523100
were expressed two- to four-fold less in FCBpfmdr1_3′KD
and 106/1 as compared to FCB (Fig. 2a, b; Additional file
5: Table S2). Interestingly, global gene expression profiles
within the amplicon region on chromosome 5 were
extremely similar between FCBpfmdr1_3′KD and 106/1
(Fig. 2a, b). Given the overlap with genes that constitute
the amplicon in the FCB strain (Additional file 6: Figure
S4), we performed quantitative real time PCR on parasite
genomic DNA to assess whether the observed transcrip-
tional differences between FCB and both FCBpfmdr1_3′KD
and 106/1 originated from different copy numbers within
the pfmdr1 region on chromosome 5. Quantitative PCR
results indicated that the FCBpfmdr1_3′KD strain has a single
copy of the genes that are found duplicated in FCB, in-
cluding pfmdr1. Furthermore, although our microarray
data showed a similar down-regulation of these genes in
106/1, the parasite strain harbored two physical copies of
these. These results with 106/1 indicate a different mech-
anism for reduced gene expression in that chromosomal
region, potentially involving silencing of one of the two
amplicons (Additional file 7: Table S3).
The same chromosomal mapping of gene expression
fold changes revealed the down-regulation of a cluster of
genes on chromosome 2 in the back-mutant strain
7G8pfcrt_T76K in comparison to the background strain
7G8 (Fig. 2c; Additional file 8: Table S4). This down-
regulation was specific to the back-mutant parasites, as
no gene expression difference was observed in that re-
gion when comparing the transgenic control strain
7G8pfcrt_CTL to 7G8 (Fig. 2d). Interestingly, many of the
affected genes encode proteins involved in parasite inva-
sion of host erythrocytes, including Merozoite Surface
Proteins (PF3D7_0206800 and PF3D7_0207000) and Serine
Repeat Antigen (SERA) gene products (PF3D7_0207400,
PF3D7_0207500, PF3D7_0207600, PF3D7_0207700, and
PF3D7_0207800) (Fig. 2c, Additional file 8: Table S4).
Genetic or transcriptional deamplification of the pfmdr1-
containing amplicon has broad transcriptional
consequences
To assess the transcriptional variations between the pro-
filed strains, we performed gene expression and gene set
enrichment analyses, considering both absolute and
normalized gene expression fold changes (Methods). We
also conducted pairwise comparisons of the transcrip-
tome data sets for three developmental stage windows,
corresponding to rings (12 to 16 h post-invasion), tro-
phozoites (24 to 28 h post-invasion) and schizonts (32 to
36 h post-invasion. These comparisons enabled us to
detect changes in genes/gene sets within a short window
of expression or genes/gene sets whose peak of ex-
pression occurred at different times between related
parasite lines (Methods; Additional file 9: Figure S5).
We observed that more than 70 % of all genes
peaked within the same 8-hour window in the
pfmdr1 dataset while about 80 % of the genes peaked
within the same 5-hour window in the pfcrt dataset
(Additional file 10: Table S5). Overall, the great ma-
jority of the observed changes was driven by changes
in gene expression levels as opposed to altered tim-
ing of expression.
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Analysis of the pfmdr1 data set (FCB vs. FCBpfmdr1_3′KD
and FCB vs. 106/1) showed that many of the genes with
significant differences in expression level encoded proteins
of unknown function. This analysis also revealed de-
creased expression of multiple genes involved in RNA and
protein metabolism upon deamplification of the pfmdr1-
containing amplicon region on chromosome 5 (Fig. 3a, b).
Among these were genes coding for RNA-binding
proteins, splicing/exosome elements and protein chaper-
ones and modifiers (Additional file 11: Table S6A,B). In
contrast, numerous genes encoding ribosomal protein
subunits, or involved in RNA translation initiation or pro-
tein turnover showed a more than two-fold higher expres-
sion level in both strains with lower pfmdr1 expression
(Fig. 3c, d). Furthermore, genes mainly involved in tran-
scriptional control, including several elements of the basal
transcription machinery, were 2 to 3.5-fold up-regulated
in FCBpfmdr1_3′KD and 106/1 in comparison to FCB. For
instance, those encoding a putative RNA polymerase II
(PF3D7_1027400), and the AP2-containing transcription
factors PF3D7_0730300 and PF3D7_0613800 [54, 55] dis-
played higher expression in FCBpfmdr1_3′KD (Additional file
11: Tables S6C). Genes encoding chromatin constituents
such as the components of the nucleosome core histone
H3 (PF3D7_0610400) and the histone variant H2B
(PF3D7_0714000) were 2 to 2.5–fold less expressed in
FCB in comparison to 106/1 (Additional file 11: Table
S6D). These results suggest an alteration of the global
transcriptional and translational activities in both strains
with reduced pfmdr1 expression in comparison to FCB.
Multiple genes implicated in cellular metabolism,
parasite remodeling and invasion also displayed higher
transcript levels in FCBpfmdr1_3′KD and 106/1 compared
to FCB (Fig. 3c, d, Additional file 11: Table S6C,D).
These observations were confirmed by applying a statis-
tical approach that we termed Hypergeometric Analysis
of Time Series (HATS), which combined Fast Fourier
Transform and GSEA, to further assess the functional
a b
c d
Fig. 2 Differential gene expression detected by chromosome mapping. a Chromosome mapping of gene expression fold differences between
FCB and FCBpfmdr1_3′KD shows differential transcription of a large fragment on chromosome 5 corresponding to the pfmdr1-containing 100-kb
amplicon region. For each gene located on chromosome 5, the expression fold difference between FCB and FCBpfmdr1_3′KD was mapped using
the chromosomal coordinates. Interestingly, PF3D7_0507500 (a subtilisin-like protease) and PF3D7_0501200 (a parasite-infected erythrocyte
surface protein) show higher expression in FCB in comparison to both FCBpfmdr1_3′KD and 106/1 (see panel B). The inset shows the genes within
the pfmdr1-containing amplicon region. b Chromosome mapping of gene expression fold differences between FCB and 106/1 for each gene on
chromosome 5 with the inset showing genes within the pfmdr1-containing amplicon region. c Chromosome mapping of gene expression fold
differences between 7G8 and 7G8pfcrt_T76K shows differential gene expression of a large number of genes located on chromosome 2 (inset shows
a cluster of genes coding for proteins involved in parasite invasion). d Chromosome mapping of gene expression fold differences between 7G8
and 7G8pfcrt_CTL for each gene on chromosome 2. In each pairwise comparison, the fold difference in gene expression was calculated as the
difference between the areas under the curve computed on the full 384 time point data
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significance of the variations in gene expression observed
between the parasite strains (see Methods). HATS, al-
though based on GSEA, imputes a gene set enrichment
score from the hypergeometric distribution of all gene sets
calculated following 1,000 random permutations, instead
of using a weighted Kolmogorov-Smirnov-like test [56].
HATS demonstrated that genes more highly expressed in
FCB in comparison to FCBpfmdr1_3′KD and 106/1 were
enriched mainly for metabolic and enzymatic activities
such as purine/pyrimidine and pyruvate/glutamate
metabolic pathways (Fig. 4a, b). In contrast, several
genes and gene sets associated with transcription
regulation, translation initiation including ribosome
biogenesis, and proteasome-mediated protein catabolism/
turnover, were depleted in FCB in comparison to both
strains with lower pfmdr1 expression (Fig. 4c, d). Stage-
enrichment analysis (Methods) revealed that these differ-
ences were detectable mainly during the trophozoite and
schizont stages (Fig. 4e, f, Additional files 12 and 13: Tables
S7 and S8 respectively). Some of these alterations, including
those affecting protein synthesis and protein turnover via
proteasome degradation have also been observed in the
transcriptional profiles of artemisinin-resistant patient iso-
lates carrying causal mutations in the kelch gene K13, sug-
gesting that these pathways might contribute to general
mechanisms adopted by multi-drug resistant parasites [57].
Further stage-specific analysis showed that gene cat-





Fig. 3 Genes with significant expression fold changes organized by categories for pairwise comparisons of the transcriptomes in the pfmdr1 data
set. Gene expression fold changes were calculated as the difference between the areas under the curve generated on the full 384 time point
data and were then normalized using a baseline created by a background pool of 11 transcriptomes. For each gene, all 55 possible pairwise
combinations of transcriptomes created a distribution of expression fold changes, which was used as a normalization factor. a Genes showing
higher expression in the parental line FCB in comparison to pfmdr1-knock-down strain FCBpfmdr1_3′KD. To identify significant differences in gene
expression, we applied a threshold of a fold change >1.5 and a normalized fold change at least 2 standard deviations (SD) above the mean. b
Genes showing higher expression in FCB in comparison to 106/1. c Genes showing lower expression in the parental line FCB compared to the
knock-down strain FCBpfmdr1_3′KD. We applied a threshold of a fold change <0.6 and a normalized fold change 3 SD below the mean. d Genes
showing lower expression in FCB in comparison to 106/1. e Venn diagrams depicting the overlap of genes with higher (fold change >1.5, left) or
lower (fold change <0.6, right) expression in FCB for the FCB vs. FCBpfmdr1_3′KD and FCB vs. 106/1 pairwise comparisons





Fig. 4 (See legend on next page.)
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to the parasite digestive vacuole were significantly
enriched (>2-fold) in FCB in comparison to FCBpfmdr1_3′
KD in mature asexual blood stages, i.e. when the digestive
vacuole is functioning. These genes included two V-type
ATPases (PF3D7_1354400, PF3D7_0519200), an AAA
family ATPase (PF3D7_0707400), an ABC transporter
(PF3D7_0810200), and drug/metabolite and amino acid
transporters (PF3D7_1428200 and PF3D7_1132500),
(Fig. 4e, Additional file 12: Table S7A,C,G). These
genes sometimes also displayed a higher expression in
FCB in comparison to 106/1 (Fig. 4f, Additional file
13: Table S8A).
Overall, the global transcriptional response to the
deamplification of the pfmdr1-containing amplicon was
highly similar between FCBpfmdr1_3′KD and 106/1. For in-
stance, expression analysis of individual genes revealed
that both FCBpfmdr1_3′KD and 106/1 strains in com-
parison to FCB showed a 2- to 3-fold down-
regulation of the genes coding for an ATP-dependent
RNA helicase (PF3D7_0521700) and the H2 ribo-
nuclease (PF3D7_0623900) (Additional file 11: Table
S6E). These two genes were among the very few that
were differentially expressed between the strains
across all time points throughout the IDC, as demon-
strated by stage-specific analysis (Additional files 12
and 13: Tables S7K and S8K respectively). HATS also
identified several gene sets that were enriched or
depleted in both FCBpfmdr1_3′KD and 106/1 in com-
parison to FCB, which included parasite transporters,
components of the proteasome degradation machinery
and ribosome constituents (Additional file 11: Table
S6G,H). Overall, we observed an overlap of greater
than 50 % in the gene sets enriched or depleted in
both FCBpfmdr1_3′KD and 106/1 in comparison to FCB
(Fig. 4g, h, Additional file 11: Table S6E,F). Interest-
ingly, we also detected enrichment for gene sets asso-
ciated with mitochondrial activities such as energy
production and electron transport in the FCB versus
106/1 pairwise comparison, but not when comparing
FCB with FCBpfmdr1_3′KD (Fig. 4a, b). These gene sets
in addition to those related to aminoacyl-tRNA bio-
synthesis, redox regulation or associated with the
parasite digestive vacuole were differentially enriched
between both pfmdr1 knock-down strains (Additional
file 14: Figure S6). The contrasting nature of the
PfCRT haplotypes between the two strains might ac-
count for these differences. This aspect was further
addressed when analyzing the pfcrt data set.
Drug-resistance mutations in pfcrt affect protein synthesis
gene expression
We applied analytical approaches similar to those de-
scribed above to the pfcrt data set (Additional file 15:
Table S9) and performed pairwise comparisons of 7G8,
7G8pfcrt_CTL and 7G8pfcrt_T76K transcriptomes. Expression
analysis for individual genes showed that several genes
encoding proteins involved in transcriptional regulation,
such as histone deacetylases (PF3D7_1472200) and specific
transcription factors (PF3D7_1222400, PF3D7_1222600)
from the ApiAP2 family were globally less expressed
in the transgenic back-mutant 7G8pfcrt_T76K and con-
trol 7G8pfcrt_CTL strains in comparison to the parental
line 7G8 (Fig. 5a, b, Additional file 15: Table S9A,B).
Additionally, genes involved in the maintenance of
mitochondrial integrity and activity, such as the mitochon-
drial import inner membrane translocase subunits TIM13
and TIM44 (PF3D7_1242900 and PF3D7_1125400, respect-
ively) and one of the cytochrome c1 precursors
(PF3D7_1462700), showed 2- to 3.5-fold lower transcript
levels in 7G8pfcrt_CTL and 7G8pfcrt_T76K in comparison to
7G8 (Fig. 5a, b, Additional file 15: Table S9A,B). Stage-
specific analysis revealed that down-regulation of the genes
encoding the TIM subunits was most apparent during the
schizont stage for both transgenic strains (Additional files
16 and 17: Tables S10E and S11E respectively), which
shared many of the genes displaying a decreased expression
when compared to 7G8 (Fig. 5c, Additional file 15: Table
S9C). On the other hand PF3D7_0609400, which encodes a
(See figure on previous page.)
Fig. 4 Hypergeometric Analysis of Time Series (HATS) for pairwise comparisons of the transcriptomes in the pfmdr1 data set. HATS was performed by
combining FFT to align the time series with a hypergeometric distribution approach based on random permutations to compute an enrichment score
for each gene set. Normalization of the enrichment scores was performed using an expression baseline constituted by a background pool of 11
transcriptome data sets (see Methods). We applied a threshold of normalized gene set rank >0.9 for gene sets we considered positively enriched and
normalized gene set rank <0.1 for gene sets considered negatively enriched. Gene sets were built using GO, KEGG and the Malaria Parasite Metabolic
Pathway (listed in Additional file 26: Table S17). a Gene sets that are enriched in FCB in comparison to FCBpfmdr1_3′KD (mean ranking values >0.9).
b Gene sets that are enriched in FCB in comparison to 106/1 (mean ranking values >0.9). c Gene sets that are depleted in FCB in comparison to
FCBpfmdr1_3′KD (mean ranking values <0.1). d Gene sets that are depleted in FCB in comparison to 106/1 (mean ranking values <0.1). e Stage-associated
enrichment analysis in FCB in comparison to FCBpfmdr1_3′KD. Gene sets with significant enrichment (orange) or depletion (blue) for three windows of
the parasite IDC correspond to rings (R, 12–16 h post-invasion), trophozoites (T, 24–28 h post-invasion) and schizonts (S, 32–36 h post-invasion). f
Stage-associated enrichment analysis in FCB in comparison to 106/1. Gene sets with significant enrichment (orange) or depletion (blue) during the
same three stages as in (E). g Venn diagrams depicting overlaps of gene sets significantly enriched in FCB (mean rank of enrichment score >0.9) for
both FCB vs. FCBpfmdr1_3′KD and FCB vs. 106/1 pairwise comparisons, as identified from our HATS analysis. h Venn diagrams depicting overlaps of
gene sets significantly depleted in FCB (mean rank of enrichment score <0.1) for both FCB vs. FCBpfmdr1_3′KD and FCB vs. 106/1 pairwise comparisons,
as identified using HATS




Fig. 5 Genes with significant expression fold changes organized by categories for pairwise comparisons of the transcriptomes in the pfcrt data
set. Gene expression fold changes were calculated as the difference between the areas under the curve generated on the full 384 time point
data and were then normalized using a baseline created by the background pool of 11 transcriptomes. For each gene, all 55 possible pairwise
combinations of transcriptomes created a distribution of expression fold changes, which was used as a normalization factor. To identify significant
differences, we applied a threshold of a fold change >1.5 and a normalized fold change at least 2 standard deviations (SD) above the mean for
higher gene expression, and a threshold of a Fold change <0.6 and a normalized fold change 3 SD below the mean for lower expression. a
Genes with higher expression in the parental line 7G8 in comparison to the recombinant control strain 7G8pfcrt_CTL. b Genes showing higher
expression in 7G8 compared to the recombinant back-mutant strain 7G8pfcrt_T76K. c Venn diagrams depicting the overlap of genes with higher
(fold change >1.5, left) or lower (fold change <0.6, right) expression in 7G8 for both 7G8 vs. 7G8pfcrt_CTL and 7G8 vs. 7G8pfcrt_T76K pairwise
comparisons. d Genes with lower expression in comparison with the recombinant control strain 7G8pfcrt_CTL. e Genes with lower expression in the
parental line 7G8 in comparison with the recombinant back-mutant strain 7G8pfcrt_T76K
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cardiolipin synthase equally central to the mitochondrial
inner membrane, was among the limited number of genes
with higher transcript levels in both transgenic strains
(Fig. 5c), particularly at the trophozoite stage (Additional
files 16 and 17: Tables S10D and S11D). These observations
suggest that decreased pfcrt expression, regardless of its
haplotype in the 7G8 background, might affect mitochon-
drial integrity and functions.
When examining the pfcrt-modified transgenic strains,
we observed increased expression in several genes en-
coding putative proteins involved in protein folding, traf-
ficking and turnover (Fig. 5d, e). These include heat
shock and DnaJ proteins, which were on average 2-fold
more highly expressed in comparison to 7G8 (Additional
file 15: Table S9D-F). Increased expression was also ob-
served with pfhrp3 (PF3D7_1372200), whose product is
hypothesized to be involved in hemozoin formation in
the parasite digestive vacuole [58]. These observations
were confirmed by HATS (Fig. 6), which provided evi-
dence for higher expression of genes in the categories of
chaperones and protein catabolism in both 7G8pfcrt_CTL
and 7G8pfcrt_T76K (Fig. 6a, b). Interestingly, there was a
substantial overlap between the gene sets depleted in
7G8 in comparison to either 7G8pfcrt_CTL or 7G8pfcrt_T76K
(Fig. 6c). Altogether these results suggest that pfcrt tran-
script levels can influence both parasite-specific processes
and general biological pathways irrespective of this trans-
porter’s drug resistance phenotype (see Discussion).
Other genes whose expression was higher in the trans-
genic 7G8 strains in comparison to the parental line
were mostly involved in parasite invasion and encoded
merozoite surface proteins as well as glideosome and
rhoptry components (Figs. 5d, e, 6a, b). Interestingly,
these effects were accentuated in the back-mutant
7G8pfcrt_T76K at both the individual gene as well as gene
set levels, during most of the parasite IDC (Fig. 7a-e,
Additional files 15 and 16: Table S9 and S10 respectively).
We also compared the transcriptional profiles of
7G8pfcrt_T76K and 7G8pfcrt_CTL to assess the impact of the
CQ resistance phenotype defined by PfCRT K76T.
Genes differentially expressed between these lines were
enriched for functions associated with DNA/RNA
metabolism and protein catabolism (Fig. 7a, b). For in-
stance, multiple genes encoding proteins possibly in-
volved in DNA replication, such as mini-chromosome
maintenance proteins (PF3D7_1355100, PF3D7_1417800),
DNA helicases (PF3D7_0918600, PF3D7_1227100, PF3D7_
1010200), a nucleotide excision repair enzyme (PF3D7_
0710400) and the DNA polymerase α subunit (PF3D7_
1463300) were ~2-fold more highly transcribed in
7G8pfcrt_CTL (Fig. 7a, Additional file 15: Table S9G). Higher
expression of some of these genes was observed throughout
the IDC as shown by stage-specific analysis (Additional file
18: Table S12). Transcripts involved in RNA processing
such as components of the exosome complex (PF3D7_
0720000, PF3D7_0209200) showed ~1.5 to 3-fold higher
levels in 7G8pfcrt_CTL, mainly during the ring and trophozo-
ite stages (Additional file 18: Table S12A,C,G). These obser-
vations were confirmed by HATS analysis (Fig. 7c, d).
Expression analysis of individual genes and gene sets
indicated that genes involved in translation and protein
stability, trafficking and turnover, such as those encoding
ribosomal subunits and protein chaperones, respectively
were also more highly transcribed in the transgenic con-
trol line 7G8pfcrt_CTL (Fig. 7a, c, Additional file 15: Table
S9G). Stage-specific analysis demonstrated that higher
expression of some of these genes was detected through-
out the entire IDC (Additional file 18: Table S12K). Fur-
thermore, HATS revealed that the categories of amino-
acyl-tRNA ligases and synthetases were depleted in the
back-mutant strain in comparison to both parental and
control lines (Figs. 6b and 7c), although several individual
genes within these categories, including some encoding a
glutamate-tRNA ligase (PF3D7_1349200 and PF3D7_
1357200), displayed higher expression in 7G8pfcrt_T76K at
either ring or schizont stages (Additional file 18: Table
S12B,F). Interestingly, HATS showed that gene sets linked
to tRNA aminoacyl biosynthesis were also enriched in
7G8pfcrt_CTL in comparison to the parental strain (Fig. 6b).
Several tRNA-ligases (PF3D7_0509600, PF3D7_1349200)
and ribosyltransferases (PF3D7_1434100) also displayed
higher transcript levels in a stage-specific manner
(Additional file 16: Table S10B,J), suggesting that
translation may also be affected when mutant pfcrt
expression is lowered (Additional file 19: Figure S7).
Pathways linked to proteasome-mediated degradation
and ribosome biogenesis were among the multiple
genes and gene sets depleted in both control and parental
strains in comparison to the back-mutant 7G8pfcrt_T76K
(Figs. 5e, 6b and 7b, d, Additional files 15: Tables S9K,L).
Altogether these observations indicate that the acquisition
of drug-resistance mutations in pfcrt may impact protein
synthesis and turnover pathways.
Expression analysis for individual genes identified sev-
eral transporters in addition to pfcrt that were differen-
tially expressed between the two transgenic strains
(Fig. 7a, b, Additional file 15: Table S9I,J), mostly in a
stage-specific manner (Additional file 18: Table S12).
This finding suggests a possible crosstalk between pfcrt
and other transporters. For example, ~2-fold higher
transcript levels of the ABC transporter PF3D7_0813700
and the folate transporter FT1 (PF3D7_0828600) were
detected in 7G8pfcrt_CTL (Additional file 18: Table
S12A,G), while genes encoding amino acid (PF3D7_
0629500) and ABC transporters (PF3D7_1229100 and
PF3D7_1352100) were ~1.5-fold more expressed in the
back-mutant during either the ring or trophozoite stages
(Additional file 18: Table S12D,F).
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Fig. 6 Hypergeometric Analysis of Time Series (HATS) for pairwise comparisons of the transcriptomes in the pfcrt data set. As for the pfmdr1
dataset, we performed HATS analysis by combining FFT to align the time series with a hypergeometric distribution approach based on random
permutations to compute an enrichment score for each gene set. Normalization of the enrichment scores was performed using the expression
baseline constituted by the background pool of 11 transcriptome data sets. As before, we applied a threshold of normalized gene set rank >0.9
for gene sets we considered positively enriched and normalized gene set rank <0.1 for gene sets considered negatively enriched. The gene
sets were built using GO, KEGG, and the Malaria Parasite Metabolic Pathway. a Gene sets that are enriched (left, mean ranking values >0.9) or
depleted (right, mean ranking values <0.1) in 7G8 in comparison with 7G8pfcrt_CTL. b Gene sets that are enriched (left, mean ranking values >0.9)
or depleted (right, mean ranking values <0.1) in 7G8 in comparison to 7G8pfcrt_T76K. c Venn diagrams depicting overlaps of gene sets significantly
enriched (left) or depleted (right) in 7G8 for both 7G8 vs. 7G8pfcrt_CTL and 7G8 vs. 7G8pfcrt_T76K pairwise comparisons
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Comparison of gene expression patterns across all
profiled transcriptomes reveals a transcriptional network
that encompasses both pfcrt and pfmdr1
Our comparative analysis of the transcriptome profiles of
the FCB- and 7G8-derived parasite lines demonstrated that
mutations and/or altered transcript levels in pfmdr1 or pfcrt
impacted the expression of similar gene categories. We
therefore assessed whether a transcriptional association be-
tween pfcrt and pfmdr1 might account for the similarities
we observed between the transcriptome data sets.
Using the publicly available transcriptome data sets of





Fig. 7 Analysis of the transcriptional differences between 7G8pfcrt_CTL and 7G8pfcrt_T76K. a Genes showing higher expression (fold change >1.5
and normalized fold change ≥2 SD above the mean) in the recombinant control 7G8pfcrt_CTL in comparison to the recombinant back-mutant
strain 7G8pfcrt_T76K. Gene expression fold changes were calculated as the difference between the areas under the curve generated on the full 384
time point data and were then normalized using a baseline created by the background pool of 11 transcriptomes. b Genes showing a lower
expression (fold change <0.6 and normalized fold change ≤3 SD below the mean) in the recombinant control 7G8pfcrt_CTL in comparison to the
recombinant back-mutant strain 7G8pfcrt_T76K. c HATS analysis was used to identify gene sets that are enriched in 7G8pfcrt_CTL in comparison to
7G8pfcrt_T76K (mean ranking values >0.9). Enrichment scores were normalized using the expression baseline constituted by the background pool
of 11 transcriptome data sets. d Gene sets that are depleted in 7G8pfcrt_CTL in comparison to 7G8pfcrt_T76K (mean ranking values <0.1), as identified
from HATS analysis. e Stage-associated enrichment analysis. Gene sets with significant enrichment (orange) or depletion (blue) in 7G8pfcrt_CTL in
comparison to 7G8pfcrt_T76K for three windows of the parasite IDC corresponding to rings (R, 12–16 h post-invasion), trophozoites (T, 24–28 h
post-invasion) and schizonts (S, 32–36 h post-invasion) using stage-enrichment analysis
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that we added to our own data sets, we first performed
an expression-based hierarchical clustering of the data,
using PCC distances between gene pairs computed
across all possible pairwise comparisons of transcrip-
tomic profiles. pfcrt and pfmdr1 ranked closely to each
other, and formed two distinguishable clusters with high
scores for gene pair correlations (Fig. 8a). One of these
clusters included a V-type ATPase localized in the para-
site digestive vacuole (PF3D7_1354400, PCC ~0.7–0.8),
a DnaJ chaperone protein (PF3D7_1307200, PCC ~0.7–
0.8) and a transcription factor of the ApiAP2 family
(PF3D7_0516800) (Additional file 20: Table S13). The
other cluster contained the RNA Polymerase I respon-
sible for rRNA transcription (PF3D7_1134700, PCC 0.8)
(Additional file 21: Table S14). Interestingly, the two
clusters also contained PF3D7_0823300 that encodes the
histone acetyltransferase GCN5 and PF3D7_0303700, a
gene involved in lipoamide synthesis, which is in
concordance with a recent study reporting the co-
expression of pfcrt with lipoamide synthesis genes
[59]. Altogether these observations suggest an associ-
ation between pfmdr1 and pfcrt expression and that
of genes with specialized functions in the digestive
vacuole, in addition to genes having more general
functions such as rRNA transcription and protein
translation.
To further investigate the transcriptional association
between pfcrt and pfmdr1, we conducted an additional
hierarchical clustering of gene expression, this time, by
ordering genes based on the level of correlation they dis-
played with either pfcrt or pfmdr1 expression (Additional
file 22: Figure S8). While more than a hundred genes
showed a high transcriptional correlation (PCC >0.7)
with each gene, we also detected a large number of
genes that were strongly anti-correlated (PCC <−0.7)
(Additional file 23: Table S15). Interestingly, many genes
(~70 %) with strong positive or negative transcriptional
correlation with pfcrt were additionally strongly corre-
lated with pfmdr1 expression (Fig. 8b). A dozen of those
genes encode transporters, components of the digestive
vacuole, or redox enzymes (Table 2). Others were linked
to DNA/RNA-dependent processes, translation, and
protein trafficking (such as components of the PTEX
parasite translocon of exported proteins) (Additional file
24: Table S16A). On the other hand, several genes impli-
cated in either RNA processing or protein catabolism,
such as those encoding splicing factors and elements of
the proteasome complex, respectively, showed a strong
anti-correlation with both pfcrt and pfmdr1 expression
(Table 2, Additional file 24: Table S16B). These find-
ings suggest the existence of a transcriptional network
that encompasses both genes and evoke a possible
a b
Fig. 8 Investigation of pfcrt and pfmdr1 expression networks: Gene expression correlations between all P. falciparum genes and pfcrt/pfmdr1.
a Cluster heatmap of expression data for P. falciparum genes. The hierarchical clustering was generated using Pearson correlation coefficients
(PCC) calculated using log2-transformed and normalized expression values of 2,600 genes across 55 pairwise comparisons of 11 parasite
transcriptome data sets. Heatmaps of the hierarchical clustering show several domains of high correlation between gene pairs, including a large
cluster corresponding to strong interactions between plasmepsin X (PF3D7_0808200) and multiple genes involved in cell motility such as myosin
(PF3D7_1246400), kinesin-like protein (PF3D7_0724900) and invasion like rhoptry (PF3D7_0414900) or IMC1-related (PF3D7_0304100) proteins.
Two smaller clusters (boxes 1 and 2) are shown including one containing both pfcrt and pfmdr1. b Venn diagrams showing the number of
genes whose expression highly correlates (PCC >0.7) (top) or anti-correlates (PCC <−0.7) (bottom) with that of both pfcrt and pfmdr1. PCC
values were calculated using log2-transformed and normalized expression values of 2600 genes across 110 pairwise comparisons of 11 parasite
transcriptome data sets
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functional association between these two drug resist-
ance transporters.
Discussion
Studies have previously defined the malaria parasite
transcriptome as hard-wired, capable only of very lim-
ited changes at the transcript level in response to spe-
cific metabolic challenges [43, 44, 60]. Nevertheless,
more recent studies have predicted gene functions and
networks using genome-wide transcriptional profiling of
P. falciparum growth perturbations, and have provided
evidence that the parasite can display transcriptional
changes even if of low amplitude in response to
chemical challenges [61]. In the present study, we have
addressed how variant forms of two primary determi-
nants of parasite drug susceptibility can affect the asex-
ual blood stage transcriptome. This focused on a
comparative analysis of the transcriptome profiles of P.
falciparum parasite lines engineered to display distinct
levels of expression and/or mutation in the genes coding
for the drug resistance transporters PfCRT and PfMDR1.
Genome-wide analysis of the transcriptomes was per-
formed both at the gene and gene set levels using com-
putational approaches that identified and excluded
transcriptional differences due to stochastic expression.
This enabled us to define a transcriptional baseline and
Table 2 Table summarizing categories of genes with strong positive (PCC >0.7) and negative correlation (PCC <−0.7) of expression
with that of both pfcrt and pfmdr1. Genes correlated or anticorrelated with pfcrt and pfmdr1 transcript levels
Categories Gene ID Description
Positively Correlated with pfcrt and pfmdr1
Transporters/Components of the digestive vacuole PF3D7_0519200 vacuolar ATP synthetase
PF3D7_0614300 organic anion transporter
PF3D7_0810200 ABC1 family, putative (ABCK1)
PF3D7_1132500 amino acid transporter, putative
PF3D7_1354400 V-type ATPase, putative
PF3D7_1456800 V-type H()-translocating pyrophosphatase, putative
PF3D7_1129900 transporter, putative
PF3D7_1454400 aminopeptidase P
PF3D7_1126000 threonine–tRNA ligase (ThrRS)
PF3D7_1332800 translation initiation factor 6, putative
Translation PF3D7_1367700 alanine–tRNA ligase (AlaRS)
PF3D7_1445100 histidine–tRNA ligase, putative
PF3D7_1204300 eukaryotic translation initiation factor 5A (EIF5A)
PF3D7_0422500 pre-mRNA-splicing helicase BRR2, putative (BRR2)
RNA metabolism PF3D7_0623900 ribonuclease H2 subunit A, putative
PF3D7_1421400 DNA-directed RNA polymerase III subunit C, putative
Negatively Correlated with pfcrt and pfmdr1
DNA/RNA metabolism PF3D7_1125300 DNA-dependent RNA polymerase
PF3D7_0105900 DNA binding protein, putative
PF3D7_0617800 histone H2A
PF3D7_1033600 Myb2 protein
PF3D7_0716100 large ribosomal subunit assembling factor, putative
PF3D7_0420400 ribosome recycling factor, putative
RNA processing/Translation PF3D7_0610100 step II splicing factor, putative
PF3D7_1446900 glutaminyl-peptide cyclotransferase, putative
PF3D7_0904600 ubiquitin specific protease, putative
Protein Catabolism PF3D7_0815700 ubiquitin
PF3D7_0413600 26S proteasome AAA-ATPase subunit RPT3, putative
Transporters PF3D7_1303500 sodium/hydrogen exchanger, Na, H antiporter
PF3D7_1352100 ABC transporter, (heavy metal transporter family), putative
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detect genes whose expression significantly diverged, im-
plicating them as candidate factors in a parasite tran-
scriptional adaptation to the pfcrt and pfmdr1 changes
that were genetically introduced.
Among the ~5,500 coding genes in P. falciparum gen-
ome, we surveyed the expression changes for a set of
3,000 to 3,500 genes for which the microarray data
passed quality inspection across at least 6 of the 8 time
points in the series. It is therefore possible that we
missed additional genes with differential transcriptional
profiles. Despite this limitation, we found that genetic
modifications of the loci coding for these two digestive
vacuole transporters notably affect the transcription of
genes coding for RNA-binding proteins, transcription
factors, elements of the translation initiation and elong-
ation machinery, and components of both the spliceo-
some and proteasome complexes. This observation was
particularly striking in the pfmdr1 data set that included
the FCB isogenic strain, FCBpfmdr1_3′KD. Deamplification
of a large region on chromosome 5 that encompassed
pfmdr1 led to the increased expression of genes involved
in translation and reduced levels of transcripts impli-
cated in protein catabolism and modifications. This
represented in total more than 10 % of the global ex-
pression changes and is concordant with expression
Quantitative Trait Loci analyses that previously demon-
strated an association between the pfmdr1-containing
amplicon and both post-translational modifications and
protein catabolic processes [62]. In agreement with that
study [62], we identified a large number of genes
involved in proteasome-mediated degradation and pro-
tein ubiquitination that display differential expression
between FCB and FCBpfmdr1_3′KD. This suggests that
amplification of the pfmdr1-containing amplicon can be
accompanied by a global reduction of DNA and RNA
metabolic activities, and increased protein catabolism.
Our study also identified mechanisms of transcrip-
tional down-regulation across the pfmdr1 amplicon in
both 106/1 (that carries two physical copies) and
FCBpfmdr1_3′KD (whose second pfmdr1 copy had been
disrupted, and for which the expression of adjacent
genes also became downregulated). Earlier studies of
Thai field isolates had shown considerable variability in
both pfmdr1 copy number and amplicon size, which
would impact expression levels of both pfmdr1 and its
neighboring genes [34]. Our data highlight the need to
account for expression when assessing the association
between pfmdr1 copy number and drug susceptibility
states, and underscore the potential for additional bio-
logical differences resulting from neighboring loci.
Differential expression of genes with a role in funda-
mental biological processes such as RNA translation,
ubiquitin-dependent catabolic processes and protein
folding/trafficking was also observed in the pfcrt data
set, albeit to a lesser extent. Gene sets associated with
these pathways showed a greater enrichment in both
7G8-derived transgenic strains that were characterized
by a decreased pfcrt transcript level, in comparison to
the parental 7G8 line. This suggests an association be-
tween the degree of pfcrt expression and the regulation
of cellular protein levels, regardless of PfCRT haplotype.
Intriguingly, levels of pfcrt transcripts, irrespective of
the transporter polymorphism, also impacted sets of
genes implicated in maintaining mitochondrial integrity
and function, as indicated by the significant decrease in
expression of genes coding for multiple subunits of the
translocase complexes of the mitochondria inner mem-
brane [63]. In contrast, the transgenic strains that differ
in the nature of the residue at position 76 in PfCRT dis-
played a differential enrichment of gene sets associated
with amino-acyl tRNA synthases and ligases. Several of
the genes coding for these elements, which play a central
role in RNA translation, were more highly expressed in
a stage-specific manner in the transgenic control in
comparison to the back-mutant strain. These findings
suggest that the impairment of PfCRT transport function
through the acquisition of resistance mutations might
impact the cellular level of amino acids. This hypothesis
is consistent with the observation that PfCRT polymor-
phisms affect hemoglobin catabolism and that CQ-
resistant parasites such as 7G8 are characterized by a
phenotype of excessive peptide accumulation, which
might in turn impact the reserve of amino acids available
for protein synthesis [64]. Additionally, the differential
expression of genes encoding putative transporters between
the two transgenic strains suggest that PfCRT resistance
mutations might more generally affect intracellular trans-
port dynamics, possibly as a secondary effect of the peptide
accumulation phenotype.
Interestingly, both pfmdr1 and pfcrt transcriptome
data sets displayed differences in the level of expression
of genes coding for invasion proteins. Higher transcript
levels of rhoptry and merozoite surface proteins, or
components of the glideosome were detected in parasite
strains with either reduced pfmdr1 expression such as
FCBpfmdr1_3′KD and 106/1 or with a PfCRT wild-type
haplotype such as the back-mutant strain 7G8pfcrt_T76K.
This, added to the observation that both CQ-sensitive
strains 106/1 and 7G8pfcrt_T76K had a shorter IDC than
the other parasites, suggests an impact of these genetic
changes on growth rates and parasite fitness [64]. Inter-
estingly, while 106/1 and FCB have genome sequences
that are almost identical [65] (suggesting a common
lineage), our data indicate notable differences in both
their PfCRT haplotype and their levels of expression
from the pfmdr1 amplicon region. By comparing FCB,
FCBpfmdr1_3′KD and 106/1, we could disentangle the tran-
scriptional changes due to lower expression/gene copy
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variation in the chromosome 5 amplicon from the effect
of different pfcrt genotypes. For instance, 106/1 appears
to express higher levels of ribosomal protein genes
compared to both FCB strains, suggesting a response
to its particular PfCRT haplotype that lacks the CQ
resistance-conferring K76T mutation. On the other
hand, our data suggest that the transcriptional down-
regulation of the pfmdr1-containing amplicon on
chromosome 5 (in 106/1 and FCBpfmdr1_3′KD) might
affect parasite physiology, notably through the re-
duced expression of genes coding for multiple trans-
porters and components of the parasite digestive
vacuole, such as ABC and drug/metabolite trans-
porters and V-type ATPases. Such an observation was
particularly striking when performing a comparative
analysis of the transcriptomes by stage, demonstrating
how such an approach can complement analyses of
gene expression averaged across time points.
Our investigations across multiple lines uncovered evi-
dence of co-regulation of pfcrt and pfmdr1, which both
also positively correlated across the genome with a suite
of genes coding for transporters, components of the
parasite digestive vacuole that include peptidases in-
volved in hemoglobin catabolism, or redox enzymes.
Conversely, pfcrt and pfmdr1 transcription anti-
correlated with a set of genes encoding proteins in-
volved in RNA processing, including splicing factors.
Broader biological processes including transcriptional
regulation, translation and post-translational process-
ing contained genes that showed either positive or
negative correlations with pfcrt and pfmdr1. Overall
this suggests the existence of an elaborate equilib-
rium in P. falciparum gene expression that maintains
optimal states of parasite physiology that extend be-
yond the digestive vacuole.
Our study builds on the recent work from Siwo and
colleagues who constructed pfcrt co-expression networks
using transcriptional measurements at the early tropho-
zoite stage for the progeny of a genetic cross between
CQ-sensitive and CQ-resistant parental strains [59].
Their analysis provided evidence that functional partners
of both CQ-resistant and CQ-sensitive pfcrt include
genes involved in hemoglobin catabolism, which agrees
with our own observations. Additionally, the authors at-
tributed divergence in co-expression networks between
CQ-resistant and CQ-sensitive pfcrt to genes involved in
DNA repair and histone acetylation. Interestingly, we
found that expression of the histone acetyltransferase
GCN5 (PF3D7_0823300) clustered with that of pfcrt and
pfmdr1, further highlighting an association between the
expression of these two transporters and general tran-
scriptional processes.
Furthermore, our data extend prior observations of
joint contributions of pfcrt and pfmdr1 polymorphisms
to drug resistance phenotypes [22, 28, 66], including evi-
dence of linkage disequilibrium, by now providing evi-
dence of a strong correlation between pfcrt and pfmdr1
transcript levels. This has direct implications for drug
resistance studies that measure pfmdr1 copy number as
a marker of decreased parasite susceptibility to antimal-
arial drugs [67] by implying an previously unrecognized
role for accompanying changes in pfcrt.
Conclusions
PfCRT and PfMDR1 are two key determinants of P.
falciparum parasite susceptibility to antimalarial com-
pounds. Both are transporters localized in the intra-
erythrocytic digestive vacuole, whose primary functions
in addition to carrying antimalarial drugs remain to date
unknown. Our transcriptome profiling of various P. fal-
ciparum strains, whose differences in pfcrt or pdmr1
coding sequence or copy number contribute directly to
multidrug resistance, provide insight into how the acqui-
sition of these genetic changes impact parasite physi-
ology beyond the digestive vacuole. These changes
include peptide catabolism, digestive vacuole homeosta-
sis, RNA metabolism and protein synthesis. Our find-
ings, based on the development of an analytical method
that we term Hypergeometric Analysis of Time Series,
also reveal a closely coordinated co-regulation of pfcrt
and pfmdr1 transcript levels. Of particular interest now
will be to further study how these transcriptional cross-
talks affect downstream processes, in particular at the
level of the parasite proteome and metabolome.
Methods
Parasite culture
All parasite lines described here were propagated under
standard conditions [68] in RPMI-1640 medium with L-
glutamine, supplemented with 50 mg/l hypoxanthine,
25 mM HEPES, 0.25 % sodium bicarbonate, 0.01 mg/ml
gentamicin and 0.5 % Albumax II (Invitrogen, Carlsbad,
CA, USA). Parasites were synchronized by two consecu-
tive sorbitol treatments timed 12 h apart for three or
more successive generations and allowed to recover for
another parasite asexual blood stage cycle before initiat-
ing time point samplings. For each time course, cultures
were progressively expanded to a volume of 250–
300 mL at 3 % hematocrit with 8 to 10 % of tightly syn-
chronous populations of late P. falciparum schizonts.
Parasites were inoculated in a bioreactor (Applikon, Fos-
ter City, CA, USA) in the presence of fresh erythrocytes
and allowed to reinvade for the next 2–3 h at high
hematocrit (8 %). Gas and temperature conditions were
monitored with a Bio Controller unit ADI 1030. The
first time point of the series was determined by the peak
of invasion, after which cultures were diluted to a final
volume of 1,000 mL and 2 % hematocrit. At least 90 %
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of the parasites were in the early ring stage and in gen-
eral, cultures reached a parasitemia of 10 to 20 %. Equal
parasite samples were harvested every 6 h throughout
the 48-hour IDC and immediately centrifuged. Pellets of
parasitized erythrocytes were directly stored in Trizol®
for subsequent RNA extraction and cDNA synthesis.
RNA preparation, cDNA synthesis and DNA microarray
hybridizations
Total RNA was isolated and synthesis of first strand
amino-allyl cDNA was performed as previously reported
[69, 70] using 125U of Superscript II reverse transcript-
ase (Invitrogen, Carlsbad, CA, USA). Each reaction was
concentrated on a Zymo DNA clean and concentrator-5
column (Zymo Research, Irvine, CA, USA) and labeled
with Cy5 dye (GE Healthcare, Piscataway, NJ, USA). The
reference RNA pool consisted of Cy3-coupled cDNA
samples prepared from RNAs representing all develop-
mental stages at 6-hour intervals of the IDC of the 3D7
line. Equal amounts of labeled samples from each time
point and reference pool were subjected to array
hybridization for 16–18 h at 65 °C on 70-mer P. falcip-
arum microarray chips that contained 10,416 features
and represented all 5,363 coding genes as previously re-
ported [70]. Data were acquired using a GenePix 4000B
scanner and analyzed with the GenePix Pro 4 software
(Molecular Devices, Sunnyvale, CA, USA).
Microarray data normalization and quality control
Automatic definition of hybridization spots was refined
by manual inspection, and acquired raw data were ini-
tially filtered to exclude poor quality spots. The Cy5 and
Cy3 intensity channels were separately normalized using
the mean difference between the median foreground in-
tensity and the median background intensity of a set of
representative probes. This set included probes that con-
tained more than 50 % of the pixels with intensities
higher than 2 standard deviations above the background
pixel intensity for both Cy5 and Cy3 signals, displayed at
least 200 expression units and a regression correlation
coefficient greater than or equal to 0.75 [48]. After back-
ground subtraction, the log2 of the (Cy5/Cy3) intensity
ratio was extracted for each probe and gene expression
ratios were computed using the median of the probe
level values. For genes with values for at least 6 of 8 time
points, missing values were imputed using linear model
prediction based on PCC values and accounting for
mean and standard deviation differences.
Transcriptomes of all lines were reconstituted using
the FFT method (fft() function in R) to sort genes ac-
cording to phase, and impute expression levels at 376
unassayed time points, one for each 7.5 min of the 48-
hour IDC. To correct for variations in developmental
stage speed between parasite lines, dynamic time warping
[71] was applied to determine the optimal post-invasion
time point (corresponding to the first sampling time
point) along the IDC using the PCC between each pair of
imputed points. Each parasite line was aligned using the
3D7 transcriptome as reference [46]. The alignments were
confirmed by applying PCA. The first two principal
components, derived from approximately 3,000 di-
mensions of expression data, accurately recapitulated
the progression of the parasite lines throughout the
IDC, while succeeding components focused on differ-
ences between parasite lines.
Microarray data analysis
To assess gene expression level differences between
parasite lines, the area under the curve (AUC) of abso-
lute gene expression plots was computed on the full 384
time point data and the fold change was calculated as
the difference between AUCs in pairwise comparisons.
OPLS-DA (Orthogonal Partial Least Square-Discriminant
Analysis) was used to create disjoint PCA models for each
parasite line [72] and exploit class-orthogonal variation,
thereby permitting the identification of genes expressed
out of phase. Both approaches resulted in a similar
gene ranking with a Spearman correlation of 0.89. To
determine significant variation between parasite lines,
a cut-off of >1.5-fold difference in gene expression
was assigned.
All values were normalized using a background pool
constituted of 11 transcriptome data sets that consti-
tuted a baseline for gene expression fold change and
gene set enrichment. In addition to that reported in the
present study, the pool included two IDC transcriptome
data sets generated for Dd2 parasites pressured long-
term with pulses of dihydroartemisinin (the 3b1 line)
and the non-pressured parent [73], as well as the tran-
scriptome data set previously reported for the 3D7, Dd2
and HB3 strains [46, 48]. This background pool was
used to generate 55 pairwise comparisons (or 110, if tak-
ing into account analysis in both directions) and create a
distribution of fold changes for each analysed gene,
which was then used as a normalizing factor. When
comparing two lines, only the remaining nine were used
to build the fold change distribution. The analysis was
conducted using a threshold of two or three standard
deviations above this mean fold change. This method,
based on a large dataset of pairwise comparisons, en-
ables us to identify even genes for which expression
changes are of small amplitudes.
To analyze gene sets, we developed an algorithm that
we termed Hypergeometric Analysis of Time Series
(HATS). The source code and pseudocode describing
HATS are provided in Additional file 25. HATS is based
on GSEA [56] and consists in assigning a rank probabil-
ity to each gene in a given gene set using GSEA and
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then applying hypergeometric distribution instead of a
weighted Kolmogorov-Smirnov-like statistic [56] to
evaluate the enrichment score. To this end, 1,000 ran-
dom permutations of the data were generated, and on
each of these permutations we calculated gene rank
probabilities P for each gene set. These probability
values were averaged per gene set across the 1,000 per-
mutations and used as a scaling factor defined as
-log10(P) to generate a corrected enrichment score from
that originally computed by GSEA. The false discovery
rate (FDR) was estimated by comparing the distributions
of the actual enrichment scores to those derived from
the random permutations. Noise reduction was achieved
by forcing all FDR values to monotonically decrease at
the tails. Finally, theses results were then normalized by
comparing them to the pool of 11 transcriptome data-
sets, across which pairwise GSEA comparisons were
conducted for all possible combinations. Means and
standard deviations of the pool-derived enrichment
scores for each gene set were computed and used to
generate normalized enrichment scores and remove sets
that were stochastically expressed. We applied a cut-off
for normalized gene set ranks of 0.1 for negatively
enriched gene sets and of 0.9 for positively enriched
gene sets.
Results were also analyzed by parasite developmental
stages, using time windows corresponding to ring,
trophozoite, and schizont stages [74]. Stage-associated
enrichment was calculated by averaging gene expression
across each developmental stage using the AUC derived
from the imputed 384-time point curve and then per-
forming GSEA. As before the enrichment scores were
calculated using the hypergeometric distribution and the
values were normalized using the background pool of
transcriptome datasets.
Gene sets were assembled from gene ontology (GO)
annotations [75], the Malaria Parasite Metabolic Path-
way [76, 77], KEGG [78] and InterPro [79] databases,
and literature searches. A summary of these gene sets is
provided in Additional file 24: Table S16. We extracted
the GO categories for P. falciparum from PlasmoDB
(www.plasmoDB.org) such that 1,664 GO categories in-
volving 4,415 genes were included. On average, there
were 3.85 categories per gene, while each GO category
contained an average of 10.2 genes. There were 16,997
GO category labels applied in total, covering 69.3 % of
the genome. On the other hand, 3,888 genes were la-
beled with an InterPro signature, averaging 3.09 labels
per gene. There were 11,997 InterPro labels applied
in total, covering 61.0 % of the genome. Finally, the
metabolic pathways of Plasmodium were extracted
from the KEGG database, such that in total 182
metabolic pathways were detailed, averaging 36.7
genes, with pathways ranging from two genes to 342
genes. 2,938 genes were part of at least one pathway,
averaging 2.3 pathways per gene. There were 6,671
metabolic pathway assignments applied in total, cov-
ering 46.1 % of the genome.
Overall, 7,682 total labels were applied, assigning 5,184
genes to 6,427 gene sets. This accounts for 81.4 % of the
genome, each gene being a member on average of 9.2
sets, with the most labeled gene being represented in 45
sets. The portion of the genome that was not repre-
sented in these sets included genes having no ascribed
functional annotation. Over- or under-representation of
a group of functional categories in comparison to all
other categories was determined using hypergeometric
distribution. Any comparison with a P-value < 0.01 was
retained.
Hierarchical clustering was performed using PCC
values obtained from all pairwise comparisons across all
11 transcriptome data sets using ratio of log2-trans-
formed and normalized gene expression values.
Quantitative real-time PCR and RT-PCR
Real-time PCR was performed in a DNA Engine Opticon
2 detector (Bio-Rad, Hercules, CA, USA) to assess tran-
script levels and gene copy numbers using the iQ SYBR
Green Supermix (Bio-Rad). Parallel amplification reac-
tions were carried out in 96-well plates in 25 μL volume
containing 0.3 to 0.5 μM of each forward and reverse
primer, with all samples run in triplicates. Measurements
were performed on three independent occasions. Primer
sequences and real-time PCR conditions are listed in
Additional file 27: Table S18.
For quantitative RT-PCR, RNA was treated with
DNase I (Ambion) to remove possible traces of contam-
inating genomic DNA. cDNA was prepared by reverse
transcription from 5 μg of total RNA using a mix of oli-
godT (Invitrogen) and random hexamers (Invitrogen).
To assess transcript levels, cDNA templates were diluted
60- to 80-fold. Relative quantification of transcripts was
performed using the standard curve method, using 10-
fold dilution series of genomic DNA harvested from the
parental strains 7G8 or FCB. cyp87 (PF3D7_0510200,
previously PFE0505w, Forward 5′ AAACGGGAGATC
CTTCAGGT, Reverse 5′ AAGGACATGGGACAGTG
GTT) was used as the reference control gene.
To assess gene copy numbers within pfmdr1 amplicon,
50 ng of template genomic DNA was used to measure
each gene copy number relative to the single-copy cyp87
or β-tubulin (PF3D7_1008700, previously PF10_0084)
genes. Assays were normalized using standard curves
that were generated by 10-fold dilution series of genomic
DNA from 3D7, known to have a single copy of pfmdr1
amplicon. Copy number results were rounded to the
nearest integer.
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Availability of supporting data
The data sets supporting the results of this article are
available in the GEO (Gene Expression Omnibus) func-
tional genomics data repository at the NCBI, under the
accession number GSE75807 (http://www.ncbi.nlm.nih.-
gov/geo/query/acc.cgi?acc=GSE75807).
Additional files
Additional file 1: Figure S1. Schema summarizing the parental and
transgenic parasite lines used in this study. (A) The FCB data set comprises
FCB, FCBpfmdr1_3′KD and 106/1 (not pictured). FCBpfmdr1_3′KD was derived from
the multidrug-resistant strain FCB by genetically disrupting one of the two
copies of the pfmdr1 gene, as reported in [26]. pBS: pBluescript plasmid
backbone. Δmdr: pfmdr1 fragment used to disrupt the coding sequence
in one of the two endogenous tandem pfmdr1 loci in FCB, resulting in
FCBpfmdr1-3′KD (knock-down). (B) The 7G8 data set comprises the CQ-resistant
parental strain 7G8 (PfCRT haplotype T76), from which two transgenic lines
were derived by allelic exchange as previously described [20], namely the
control 7G8pfcrt_CTL (moderately CQ-resistant, PfCRT haplotype T76)
and the back-mutant 7G8pfcrt_T76K that is now fully CQ-sensitive
(PfCRT haplotype K76). (PDF 347 kb)
Additional file 2: Table S1. Validation of the data point imputation.
Using the publically available transcriptome datasets for 3D7, Dd2 and
HB3 from (Llinas et al. NAR 2007), we validated whether the density of
the data in our time series (of eight points, at a 6-hour resolution) was
sufficient to impute data to a 7.5 min resolution. For each strain, we
selected eight time points evenly spread (6-hrs apart) from which we
generated an imputed curve of 384 points. Using Pearson correlation
values for gene expression, we then compared each actual hourly time
point to the imputed curve to identify the closest matching time point.
The imputed percentage column shows where the match occurred in
the time series. Actual time points from the original time courses
match imputed time points that are fairly evenly spread along the
imputation-derived curve. (XLSX 37 kb)
Additional file 3: Figure S2. Heatmaps showing alignment of each
profiled transcriptome to that of 3D7. FFT was used to impute expression
levels from the 8 sampled time points across a data set of 384 time
points spanning the 48-hour IDC. This allowed expression level to be
extrapolated with close temporal resolution (7.5 min) across the IDC.
Dynamic time warping was used to align all 384 points to those of
the published 3D7 time series [48, 70], using the PCC score computed
between each pair of points. (PDF 2732 kb)
Additional file 4: Figure S3. Example of a chromosome map showing
differential gene expression in the telomeric regions of chromosome
11 between FCB and both FCBpfmdr1_3′KD and 106/1. Expression fold
changes for both pairwise comparisons were plotted as a function of the
chromosomal coordinates of each gene. Each circle represents a distinct
gene. The dashed line delineates the threshold value of a 1.5 fold shift
that was interpreted as evidence of transcriptional differences. Note
that the (sub)telomeric regions of chromosome 11 are enriched in
transcriptionally variable multigene families, notably var and phist
genes. (PDF 129 kb)
Additional file 5: Table S2. List of genes within the pfmdr1-containing
amplicon with associated fold change between FCB and both FCBpfmdr1_3′
KD and 106/1, as measured by microarrays. (XLSX 11 kb)
Additional file 6: Figure S4. Genomic map of the pfmdr1-containing
amplicon region on chromosome 5 of the FCB strain. Genes listed in
Additional file 2: Table S1 are indicated and pfdmr1 (PF3D7_052300) is
boxed in red. (PDF 90 kb)
Additional file 7: Table S3. Results of quantitative real time PCR
to estimate gene copy numbers associated with gene expression
variations between FCB and both FCB_3′KD and 106/1 in the
pfmdr1-containing amplicon region on chromosome 5. These
data suggest dosage compensation for the gene Pf3D7_0521300.
(XLSX 57 kb)
Additional file 8: Table S4. Values for gene expression fold differences
between strains in the 7G8 data set for genes on chromosome 2. The
boxed area corresponds to the region on chromosome 2 containing
genes with a significant fold change (values <0.6). (XLSX 13 kb)
Additional file 9: Figure S5. Venn diagrams depicting the number of
genes that were found differentially expressed between FCB and (A)
FCBpfmdr1_3′KD or (B) 7G8pfcrt_CTL and 7G8pfcrt_T76K during one or more
developmental stages. Fold changes greater than 1.5 and normalized
fold changes two standard deviations above the median value were
used for the analyses. (PDF 82 kb)
Additional file 10: Table S5. Assessment of a possible time shift in
gene expression between parasite lines. We examined the data to assess
whether some genes displayed a shifted timing of expression between
parasite strains. By comparing peaks of expression for each gene in
each pairwise comparison, we determined the number of genes whose
peak of expression was shifted of a determined number of hours. 0
corresponds to a shift of less than 1 h, one corresponds to a shift of at
least 1 h but less than two hours, etc. Therefore, two genes cannot be
more than 24 h apart of each other in either direction. We observed
that more than 70 % of all genes peaked within the same 8-hour
window in the pfmdr1 dataset (Table S5A) while about 80 % of the
genes peaked within the same 5-hour window in the pfcrt dataset
(Table S5B). (XLSX 44 kb)
Additional file 11: Table S6 Genes (A-D) and gene sets (E-H)
differentially expressed in the pfmdr1 data set. For each pairwise
comparison, we listed genes with significant differential expression, i.e.
with a fold change greater than 1.5 and a normalized fold change two
standard deviations above the median values and genes with a fold
change lower than 0.6 and a normalized fold change three standard
deviations below the median value, which generally represented the
quasi-totality of genes with a fold change below 0.6. Normalization
was performed using the average fold change computed across a
background pool of 11 transcriptome data sets as a scaling factor.
This normalization allowed us to identify and filter out most of the
hypervariable genes (e.g. var, rifin, stevor, phist, and hyp). Antigenically
variant genes not detected by automatic filtering were manually removed.
We listed the gene sets with significant differential expression (based on
the mean rank of enrichment score >0.9 (significantly enriched) or <0.1
(significantly impoverished)) that are found in both FCB vs. FCBpfmdr1_3′KD
and FCB vs. 106/1 pairwise comparisons. (XLSX 65 kb)
Additional file 12: Table S7. List of genes with significant differential
expression between FCB and FCBpfmdr1_3′KD in a stage-specific manner.
Genes with significantly higher expression displayed absolute fold change
values >1.5 and normalized fold changes values two standard deviations
above the median normalized fold change value. Fold change for each
gene at the designated stage is indicated. No gene appeared to be
significantly differently expressed between the two strains during both
ring and schizont stages. Genes from antigenic variant families have
been removed. (XLSX 71 kb)
Additional file 13: Table S8. List of genes with significant differential
expression between FCB and 106/1 in a stage-specific manner. Genes
with significantly higher expression displayed absolute fold changes >1.5
and normalized fold changes values two standard deviations above the
median normalized fold change value. Genes with significantly lower ex-
pression had absolute fold change values lower than 0.6 and a normal-
ized fold change three standard deviations below the median value. Fold
change for each gene at the designated stage is indicated. (XLSX 66 kb)
Additional file 14: Figure S6. Gene set enrichment analysis for the
FCBpfmdr1_3′KD vs 106/1 pairwise comparison. Gene sets that are
significantly (A) enriched (A) or (B) depleted in FCBpfmdr1_3′KD in
comparison with 106/1. We also performed an analysis of the overlap for
(C) enriched and (D) depleted gene sets between FCBpfmdr1_3′KD vs 106/1
and FCB vs 106/1 comparisons. (PDF 162 kb)
Additional file 15: Table S9. Genes (A-F, I-K) and gene sets (G-H, L-M)
differentially expressed in the pfcrt data set. For each pairwise
comparison, 7G8 vs 7G8pfcrt_CTL, 7G8 vs 7G8pfcrt_T76K, and 7G8pfcrt_CTL vs
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7G8pfcrt_T76K, we listed genes with significant differential expression, i.e.
with a fold change greater than 1.5 and a normalized fold change two
standard deviations above the median values. We listed the gene sets
significantly enriched and depleted in 7G8 in comparison with both
7G8pfcrt_CTL and 7G8pfcrt_T76K, and in 7G8 and 7G8pfcrt_CTL in comparison to
7G8pfcrt_T76K. (XLSX 48 kb)
Additional file 16: Table S10. List of genes with significant differential
expression between 7G8 and 7G8pfcrt_CTL in a stage-specific manner.
Genes with significantly higher expression displayed absolute fold changes
>1.5 and normalized fold changes values two standard deviations above
the median normalized fold change value. Genes with significantly lower
expression had absolute fold change values lower than 0.6 and a normalized
fold change three standard deviations below the median value. Fold change
for each gene at the designated stage is indicated. (XLSX 55 kb)
Additional file 17: Table S11. Genes with significant differential
expression between 7G8 and 7G8pfcrt_T76K in a stage-specific manner.
Genes with significantly higher expression displayed absolute fold
changes >1.5 and normalized fold changes values two standard deviations
above the median normalized fold change value. Genes with significantly
lower expression had absolute fold change values lower than 0.6 and a
normalized fold change three standard deviations below the median value.
Fold change for each gene at the designated stage is indicated. (XLSX 59 kb)
Additional file 18: Table S12. Genes with significant differential
expression between 7G8pfcrt_CTL and 7G8pfcrt_T76K in a stage-specific
manner. Genes with significantly higher expression displayed absolute
fold changes >1.5 and normalized fold changes values two standard
deviations above the median normalized fold change value. Genes
with significantly lower expression had absolute fold change values
lower than 0.6 and a normalized fold change three standard deviations
below the median value. Fold change for each gene at the designated
stage is indicated. (XLSX 58 kb)
Additional file 19: Figure S7. Gene sets with significant enrichment
(orange) or depletion (blue) in 7G8 in comparison to 7G8pfcrt_CTL for
three windows of the parasite IDC corresponding to rings (R, 12–16 h
post-invasion), trophozoites (T, 24–28 h post-invasion) and schizonts
(S, 32–36 h post-invasion). (PDF 110 kb)
Additional file 20: Table S13. Hierarchical clustering, which was
performed using Pearson correlation coefficients between ~2600 gene
pairs across 55 pairwise comparisons of 11 parasite transcriptome data
sets, including FCB and 7G8 data sets. Cluster 1 corresponding to
gene pairs with high Pearson correlation (PCC >0.7), containing pfmdr1
and pfcrt as well as a transcription factor of the ApiAP2 family
PF3D7_0516800. (XLSX 42 kb)
Additional file 21: Table S14. Cluster 2 from the Hierarchical clustering,
corresponds to another group of gene pairs with high Pearson correlation
(PCC >0.7) and includes pfmdr1 and pfcrt. (XLSX 46 kb)
Additional file 22: Figure S8. Cluster heatmap of gene expression
data for pfcrt/pfmdr1 and all other genes. The hierarchical clustering
was generated using PCC values calculated using log2-transformed
and normalized expression values of 2,600 genes across 110 pairwise
comparisons of 11 parasite transcriptome data sets, corresponding to
all possible combinations in both directions (i.e. A vs. B and B vs. A).
Squares indicate areas containing genes that are all strongly correlated
or strongly anti-correlated with the expression of both pfcrt and pfmdr1.
(PDF 499 kb)
Additional file 23: Table S15. Gene expression correlation between
P. falciparum genes and either pfcrt or pfmdr1. Pearson correlation coefficients
were calculated between pfcrt/pfmdr1 expression values and those of other
2,600 P. falciparum genes across 110 pairwise comparisons. These correspond
to bi-directional comparisons between 11 parasite transcriptome data sets,
including FCB and 7G8 data sets. (A) List of genes whose expression is highly
correlated (PCC >0.7) to that of pfcrt. (B) List of genes whose expression is
highly anti-correlated (PCC <−0.7) to that of pfcrt. (C) List of genes whose
expression is highly correlated (PCC >0.7) to that of pfmdr1. (D) List of genes
whose expression is highly anti-correlated (PCC <−0.7) to that of pfmdr1.
Corresponding Spearman correlations are also indicated. (XLSX 87 kb)
Additional file 24: Table S16. Identification of genes whose expression
is strongly correlated to that of both pfcrt and pfmr1. PCC were estimated
from 110 pairwise comparisons of 11 transcriptome data sets. (A) List of
genes organized by functional categories whose expression is highly
correlated (PCC >0.7) to that of both pfcrt and pfmdr1. *Indicates
genes with confidence, as found when using PCC computed from 55
unidirectional pairwise comparisons of the 11 transcriptome data sets.
(B) List of genes organized by functional categories whose expression
is highly anti-correlated (PCC<−0.7) to that of both pfcrt and pfmdr1.
*Indicates genes with confidence, as found when using PCC computed
from 55 unidirectional pairwise comparisons of the 11 transcriptome
data sets. (XLSX 42 kb)
Additional File 25: Zipped file folder containing code and
pseudocode for HATS analysis. These files can be downloaded from
http://www.fidock.org/data/fidock_source_code.zip. (DOCX 32 kb)
Additional File 26: Table S17. Table summarizing all the gene sets,
extracted from various databases or built by our group, that were used
in this study. (XLSX 688 kb)
Additional file 27: Table S18. List of the primers used for the qPCR
and qRT-PCR reactions. (XLSX 31 kb)
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